article thumbnail

AAFP Represents Members During 2025 Legislative Session

Alabama Academy of Family Physicians

During the session, the Alabama Academy of Family Physicians actively represented the interests of its members on a range of healthcare initiatives. Pharmacy benefits managers would be prohibited under this bill from barring disclosure of information by pharmacists to consumers about drug costs and alternative drugs for treatment.

Insurance 130
article thumbnail

Zicam and Orajel Swabs Recalled for Possible Fungal Contamination

Physician's Weekly

Food and Drug Administration (FDA) after the manufacturer, Church & Dwight Co., More information Read the full recall notice at the U.S. THURSDAY, June 12, 2025 (HealthDay News) — Some nasal and baby teething swabs from Zicam and Orajel are being recalled across the country because they may be contaminated with fungus, U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is my Software a Medical Device? Use the Digital Health Policy Navigator

FDA Law Blog

If you are a manufacturer of implants that go into the human body for the treatment of disease, it’s an easy yes that you are a manufacturer of a medical device. It identifies key questions to consider that originate from a variety of FDA guidance documents and aggregates the information into a one-stop shop.

Medical 23
article thumbnail

The Most Engaging Decision You’ll Read All Year – Five Stars

FDA Law Blog

FDA , Petitioners, a liquid nicotine manufacturer, sued FDA arguing that the Agency was arbitrary and capricious in rejecting the Petitioner’s Premarket Tobacco Application (“PMTA”) in violation of the Administrative Procedure Act (“APA”). Youth behavioral data was not specifically required but FDA encouraged such information.

article thumbnail

Maine and Nevada Update Drug Price Transparency Laws

FDA Law Blog

Schlanger — Maine and Nevada previously enacted laws requiring drug manufacturers to report information about the pricing of their products. Both states’ new requirements will become effective in October 2021 and should be considered as manufacturers prepare for state drug price transparency reporting in 2022.

article thumbnail

It’s a Bird, It’s a Plane, It’s Operation Stork Speed

FDA Law Blog

This initiative seeks to address the ongoing challenges families face in ensuring they have access to safe, reliable, and nutritious infant formula and is described by HHS Secretary Kennedy as critical to the pursuit of Make America Healthy Again.

Family 59
article thumbnail

PhRMA Code Revised in Response to OIG Special Fraud Alert on Speaker Programs

FDA Law Blog

Kirschenbaum — On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced the release of a revised PhRMA Code on Interactions with Health Care Professionals , which takes effect on January 1, 2022. not friends, significant others, or family members of a speaker or invitee). By McKenzie E.